跳至主要内容
临床试验/NCT02582450
NCT02582450Unknown不适用

Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia. Veritas-Pro Project

Real Fundación Victoria Eugenia1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
70
试验地点
1
主要终点
Translation of the original questionnaire (English) to Spanish

研究概览

简要总结

Research project for validation of a questionnaire on compliance to treatment in patients with hemophilia. It is intended to validate the American VERITAS-PRO scale according to the international methodology validation questionnaires: reverse translation, according to intersubject patients, psychometric validation and reliability analysis with large sample of patients.

详细描述

The validated questionnaire obtained in this project will identify the actual degree of patient compliance to drug therapy, using as gold standard the difference between the treatment prescribed and administered.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
13 Years 至 65 Years(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients with hemophilia A and B
  • Patients who have previously signed the informed consent document

排除标准

  • Patients with other congenital coaghulopatías (eg, Von Willebrand's disease)
  • Patients with cognitive impairment, or oral or written understanding

结局指标

主要结局

Translation of the original questionnaire (English) to Spanish

时间窗: 1 day (Screening visit)

Three health experienced in the treatment of hemophilia and knowledge of English, translated into Spanish the HAL and HEP questionnaire. Two native speakers (English and Spanish), reverse-translate the original text of the HAL and HEP questionnaires and the text translated by the Spanish health.

The translated version of the questionnaire

时间窗: 1 day (Screening visit)

10 patients with hemophilia adults enrolled randomly will participate in the pilotage. The clarity of the questions in Spanish translated version and the relevance of each of the items of the questionnaires will be evaluated.

Sending the questionnaire to a large sample of patients for final validation

时间窗: 1 day (Screening visit)

70 patients with hemophilia will participate in the pilotage. The validity and reliability of the Spanish version translated from the questionnaires will be assessed.

次要结局

未报告次要终点

研究者

发起方
Real Fundación Victoria Eugenia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验